Joel Rothman
Corporate Officer/Principal bei EQUILLIUM, INC.
Vermögen: 134 327 $ am 31.03.2024
Profil
Joel M.
Rothman is currently the Chief Development Officer at Equillium, Inc. He previously worked as the Director-Regional Operations at ICON Clinical Research, Inc. from 1998 to 2004, Vice President at Cytokinetics, Inc. from 2017 to 2018, Vice President-Development Operations at Jazz Pharmaceuticals, Inc., and Vice President at Raptor Pharmaceuticals, Inc. from 2015 to 2017.
Rothman received his undergraduate degree from Albright College and his graduate degree from Massachusetts Institute of Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
EQUILLIUM, INC.
0,16% | 02.01.2024 | 58 150 ( 0,16% ) | 134 327 $ | 31.03.2024 |
Aktive Positionen von Joel Rothman
Unternehmen | Position | Beginn |
---|---|---|
EQUILLIUM, INC. | Corporate Officer/Principal | 01.01.2021 |
Ehemalige bekannte Positionen von Joel Rothman
Unternehmen | Position | Ende |
---|---|---|
CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01.09.2018 |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Corporate Officer/Principal | 01.01.2017 |
ICON Clinical Research, Inc.
ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Corporate Officer/Principal | 01.07.2004 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Ausbildung von Joel Rothman
Albright College | Undergraduate Degree |
Massachusetts Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CYTOKINETICS, INCORPORATED | Health Technology |
EQUILLIUM, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
ICON Clinical Research, Inc.
ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Commercial Services |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Health Technology |